Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Transcription Factors | 10 | 2022 | 12131 | 0.490 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2018 | 647 | 0.460 |
Why?
|
Hematologic Diseases | 1 | 2018 | 500 | 0.460 |
Why?
|
Myelodysplastic Syndromes | 4 | 2022 | 1404 | 0.440 |
Why?
|
Leukemia, Myeloid, Acute | 3 | 2018 | 3646 | 0.370 |
Why?
|
Oligopeptides | 1 | 2016 | 1192 | 0.360 |
Why?
|
Gene Expression Regulation, Leukemic | 2 | 2013 | 657 | 0.340 |
Why?
|
Magnetite Nanoparticles | 4 | 2012 | 309 | 0.270 |
Why?
|
Drug Resistance, Multiple | 4 | 2012 | 255 | 0.260 |
Why?
|
Leukemia | 3 | 2011 | 1522 | 0.250 |
Why?
|
Hydroxamic Acids | 2 | 2019 | 483 | 0.210 |
Why?
|
Daunorubicin | 4 | 2012 | 157 | 0.210 |
Why?
|
Hematopoiesis | 1 | 2012 | 2058 | 0.210 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2018 | 618 | 0.200 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2014 | 2844 | 0.190 |
Why?
|
Neural Stem Cells | 2 | 2020 | 898 | 0.190 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2019 | 777 | 0.180 |
Why?
|
Mice, SCID | 6 | 2021 | 2630 | 0.180 |
Why?
|
Hematopoietic Stem Cells | 2 | 2013 | 3401 | 0.180 |
Why?
|
Fusion Proteins, bcr-abl | 2 | 2013 | 430 | 0.170 |
Why?
|
Borates | 1 | 2019 | 17 | 0.170 |
Why?
|
Bromides | 1 | 2019 | 22 | 0.170 |
Why?
|
Ionic Liquids | 1 | 2019 | 11 | 0.170 |
Why?
|
Archaea | 1 | 2019 | 59 | 0.160 |
Why?
|
Epigenesis, Genetic | 1 | 2013 | 3819 | 0.160 |
Why?
|
Mice, Inbred NOD | 4 | 2021 | 1837 | 0.160 |
Why?
|
Caveolin 1 | 1 | 2020 | 255 | 0.160 |
Why?
|
Multiple Myeloma | 1 | 2016 | 5197 | 0.150 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2019 | 227 | 0.150 |
Why?
|
Peroxynitrous Acid | 1 | 2018 | 40 | 0.150 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2016 | 9373 | 0.150 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 1 | 2019 | 266 | 0.140 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 2013 | 689 | 0.140 |
Why?
|
Ferric Compounds | 2 | 2009 | 368 | 0.140 |
Why?
|
Apoptosis | 7 | 2021 | 9514 | 0.140 |
Why?
|
K562 Cells | 7 | 2012 | 649 | 0.130 |
Why?
|
Oncogenes | 1 | 2022 | 1235 | 0.130 |
Why?
|
Up-Regulation | 2 | 2022 | 4137 | 0.120 |
Why?
|
Selenium-Binding Proteins | 1 | 2014 | 18 | 0.120 |
Why?
|
Gene Expression Regulation | 1 | 2012 | 11888 | 0.110 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 1 | 2018 | 245 | 0.110 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2018 | 361 | 0.110 |
Why?
|
Homeodomain Proteins | 2 | 2013 | 2428 | 0.110 |
Why?
|
Imidazoles | 1 | 2019 | 1162 | 0.110 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2021 | 3608 | 0.110 |
Why?
|
Benzylisoquinolines | 2 | 2012 | 15 | 0.110 |
Why?
|
Leukemia, Monocytic, Acute | 1 | 2013 | 58 | 0.100 |
Why?
|
Histone Deacetylase 2 | 1 | 2013 | 71 | 0.100 |
Why?
|
HL-60 Cells | 1 | 2013 | 364 | 0.100 |
Why?
|
Histone Deacetylase 1 | 1 | 2013 | 132 | 0.100 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2012 | 5337 | 0.100 |
Why?
|
Flavanones | 1 | 2012 | 75 | 0.100 |
Why?
|
Cell Culture Techniques | 1 | 2019 | 1652 | 0.100 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2021 | 8611 | 0.090 |
Why?
|
Neurogenesis | 1 | 2018 | 866 | 0.090 |
Why?
|
Dexamethasone | 1 | 2018 | 1963 | 0.090 |
Why?
|
Mice | 13 | 2021 | 81819 | 0.090 |
Why?
|
Genes, MDR | 1 | 2010 | 36 | 0.090 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2013 | 308 | 0.090 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2013 | 2329 | 0.090 |
Why?
|
PTEN Phosphohydrolase | 2 | 2013 | 1119 | 0.090 |
Why?
|
Antigens, CD34 | 1 | 2012 | 656 | 0.090 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2012 | 857 | 0.080 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2010 | 220 | 0.080 |
Why?
|
Xanthones | 1 | 2009 | 23 | 0.080 |
Why?
|
Combined Modality Therapy | 2 | 2018 | 8529 | 0.080 |
Why?
|
Risk | 2 | 2018 | 9591 | 0.080 |
Why?
|
Bacteria | 1 | 2019 | 2209 | 0.080 |
Why?
|
Graft Survival | 1 | 2019 | 3890 | 0.080 |
Why?
|
Hyperthermia, Induced | 1 | 2012 | 415 | 0.080 |
Why?
|
Interleukin-10 | 1 | 2014 | 1183 | 0.070 |
Why?
|
Animals | 16 | 2021 | 168764 | 0.070 |
Why?
|
Feedback, Physiological | 1 | 2010 | 480 | 0.070 |
Why?
|
Drug Design | 1 | 2013 | 1042 | 0.070 |
Why?
|
Ferrosoferric Oxide | 1 | 2009 | 349 | 0.070 |
Why?
|
DNA Methylation | 1 | 2021 | 4424 | 0.070 |
Why?
|
Nanoparticles | 2 | 2009 | 1964 | 0.070 |
Why?
|
Whole Blood Coagulation Time | 1 | 2007 | 29 | 0.070 |
Why?
|
Myelopoiesis | 1 | 2008 | 135 | 0.070 |
Why?
|
Myeloproliferative Disorders | 1 | 2013 | 616 | 0.070 |
Why?
|
Liver Neoplasms | 2 | 2013 | 4353 | 0.070 |
Why?
|
Tumor Cells, Cultured | 4 | 2021 | 6113 | 0.070 |
Why?
|
Antineoplastic Agents | 4 | 2022 | 13648 | 0.070 |
Why?
|
Dextrans | 1 | 2009 | 571 | 0.070 |
Why?
|
Morpholines | 1 | 2010 | 577 | 0.070 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 2008 | 249 | 0.070 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2008 | 434 | 0.060 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2013 | 2505 | 0.060 |
Why?
|
Lymphoma | 1 | 2014 | 1897 | 0.060 |
Why?
|
Drug Carriers | 1 | 2009 | 700 | 0.060 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2006 | 386 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2013 | 2453 | 0.060 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2012 | 3797 | 0.060 |
Why?
|
Platelet Transfusion | 1 | 2007 | 296 | 0.060 |
Why?
|
Cell Cycle | 1 | 2012 | 2920 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4562 | 0.050 |
Why?
|
Endometrial Neoplasms | 1 | 2013 | 1378 | 0.050 |
Why?
|
Polymorphism, Genetic | 1 | 2014 | 4247 | 0.050 |
Why?
|
Pluripotent Stem Cells | 1 | 2010 | 807 | 0.050 |
Why?
|
Polymerase Chain Reaction | 1 | 2012 | 6069 | 0.050 |
Why?
|
Embryonic Stem Cells | 1 | 2010 | 1241 | 0.050 |
Why?
|
Cell Differentiation | 4 | 2018 | 11641 | 0.050 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2011 | 3607 | 0.050 |
Why?
|
epsilon-Globins | 1 | 2022 | 2 | 0.050 |
Why?
|
Humans | 28 | 2022 | 765968 | 0.050 |
Why?
|
Cell Proliferation | 5 | 2021 | 10429 | 0.050 |
Why?
|
RNA, Messenger | 3 | 2014 | 12768 | 0.050 |
Why?
|
Antibiotics, Antineoplastic | 3 | 2010 | 679 | 0.050 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2011 | 1434 | 0.050 |
Why?
|
Iron | 1 | 2010 | 1816 | 0.050 |
Why?
|
RNA, Small Interfering | 1 | 2010 | 3421 | 0.050 |
Why?
|
Protein Binding | 3 | 2022 | 9296 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11868 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2016 | 8041 | 0.040 |
Why?
|
Neoplasms | 3 | 2022 | 22340 | 0.040 |
Why?
|
Peptide Fragments | 1 | 2013 | 5125 | 0.040 |
Why?
|
Glucosidases | 1 | 2019 | 12 | 0.040 |
Why?
|
Incidence | 1 | 2018 | 21480 | 0.040 |
Why?
|
Urease | 1 | 2019 | 43 | 0.040 |
Why?
|
Caspase 3 | 2 | 2012 | 731 | 0.040 |
Why?
|
Acid Phosphatase | 1 | 2019 | 139 | 0.040 |
Why?
|
Signal Transduction | 3 | 2019 | 23601 | 0.040 |
Why?
|
Chromosome Aberrations | 1 | 2006 | 1774 | 0.040 |
Why?
|
Doxorubicin | 3 | 2010 | 2230 | 0.040 |
Why?
|
Enzyme Inhibitors | 1 | 2010 | 3715 | 0.040 |
Why?
|
Soil Microbiology | 1 | 2019 | 92 | 0.040 |
Why?
|
Thrombocytopenia | 1 | 2007 | 1171 | 0.040 |
Why?
|
GATA2 Transcription Factor | 1 | 2019 | 158 | 0.040 |
Why?
|
Soil | 1 | 2019 | 123 | 0.040 |
Why?
|
Ammonia | 1 | 2019 | 244 | 0.040 |
Why?
|
Nanomedicine | 2 | 2012 | 286 | 0.040 |
Why?
|
Immunization, Passive | 1 | 2020 | 616 | 0.040 |
Why?
|
Binding Sites | 3 | 2013 | 6001 | 0.040 |
Why?
|
Liver | 1 | 2013 | 7562 | 0.040 |
Why?
|
Oxidoreductases | 1 | 2019 | 409 | 0.030 |
Why?
|
Transcription, Genetic | 1 | 2010 | 7599 | 0.030 |
Why?
|
Blood Platelets | 1 | 2007 | 2464 | 0.030 |
Why?
|
Benzamides | 1 | 2021 | 1377 | 0.030 |
Why?
|
Transplantation, Heterologous | 2 | 2014 | 2394 | 0.030 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2012 | 5753 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2019 | 9550 | 0.030 |
Why?
|
Mice, Inbred ICR | 1 | 2014 | 339 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2019 | 2218 | 0.030 |
Why?
|
Rats | 2 | 2020 | 23707 | 0.030 |
Why?
|
DNA-Binding Proteins | 1 | 2010 | 9601 | 0.030 |
Why?
|
COS Cells | 1 | 2014 | 1136 | 0.020 |
Why?
|
Magnetic Field Therapy | 1 | 2012 | 27 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2014 | 18071 | 0.020 |
Why?
|
Phylogeny | 1 | 2019 | 2832 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2014 | 11083 | 0.020 |
Why?
|
Cyclin E | 1 | 2012 | 156 | 0.020 |
Why?
|
Caspase 8 | 1 | 2012 | 198 | 0.020 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2012 | 202 | 0.020 |
Why?
|
Base Sequence | 2 | 2013 | 12403 | 0.020 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2014 | 456 | 0.020 |
Why?
|
bcl-2-Associated X Protein | 1 | 2012 | 283 | 0.020 |
Why?
|
Cell Line, Tumor | 3 | 2014 | 17075 | 0.020 |
Why?
|
Gene Expression | 2 | 2013 | 7584 | 0.020 |
Why?
|
Promoter Regions, Genetic | 2 | 2013 | 5786 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 2013 | 1770 | 0.020 |
Why?
|
Antibodies, Neutralizing | 1 | 2020 | 2010 | 0.020 |
Why?
|
Drugs, Chinese Herbal | 1 | 2012 | 142 | 0.020 |
Why?
|
Cell Survival | 2 | 2012 | 5747 | 0.020 |
Why?
|
Chromatin | 1 | 2022 | 2980 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2013 | 2014 | 0.020 |
Why?
|
Pyridines | 1 | 2021 | 2888 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2020 | 3513 | 0.020 |
Why?
|
Inhibitory Concentration 50 | 1 | 2010 | 461 | 0.020 |
Why?
|
Transferrin | 1 | 2010 | 283 | 0.020 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2013 | 691 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2020 | 3211 | 0.020 |
Why?
|
Metabolic Networks and Pathways | 1 | 2013 | 798 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2013 | 1718 | 0.020 |
Why?
|
Pneumonia | 1 | 2020 | 2157 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2020 | 4528 | 0.020 |
Why?
|
Receptors, Transferrin | 1 | 2010 | 300 | 0.020 |
Why?
|
Interleukin-18 | 1 | 2010 | 251 | 0.020 |
Why?
|
Neoplasm, Residual | 1 | 2013 | 1009 | 0.020 |
Why?
|
Inositol 1,4,5-Trisphosphate | 1 | 2008 | 110 | 0.020 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2010 | 348 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2020 | 3584 | 0.020 |
Why?
|
Myeloid Progenitor Cells | 1 | 2008 | 112 | 0.020 |
Why?
|
Critical Illness | 1 | 2020 | 2744 | 0.020 |
Why?
|
Bleeding Time | 1 | 2007 | 83 | 0.020 |
Why?
|
Ferritins | 1 | 2010 | 600 | 0.020 |
Why?
|
Blood Cell Count | 1 | 2008 | 405 | 0.020 |
Why?
|
Down-Regulation | 1 | 2014 | 2927 | 0.020 |
Why?
|
Multigene Family | 1 | 2010 | 1080 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2013 | 14652 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2018 | 8102 | 0.020 |
Why?
|
Male | 6 | 2018 | 363698 | 0.020 |
Why?
|
Partial Thromboplastin Time | 1 | 2007 | 202 | 0.020 |
Why?
|
DNA Primers | 1 | 2010 | 2825 | 0.020 |
Why?
|
Magnetics | 1 | 2009 | 585 | 0.020 |
Why?
|
Mice, Nude | 1 | 2012 | 3618 | 0.020 |
Why?
|
RNA Interference | 1 | 2014 | 2832 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2012 | 1410 | 0.020 |
Why?
|
Drug Synergism | 1 | 2009 | 1749 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2013 | 4260 | 0.010 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2013 | 1560 | 0.010 |
Why?
|
Platelet Count | 1 | 2007 | 782 | 0.010 |
Why?
|
Karyotyping | 1 | 2006 | 1178 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2012 | 6220 | 0.010 |
Why?
|
Alleles | 1 | 2014 | 6897 | 0.010 |
Why?
|
Transfection | 1 | 2010 | 5743 | 0.010 |
Why?
|
Female | 5 | 2013 | 396112 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2018 | 18973 | 0.010 |
Why?
|
Prognosis | 2 | 2013 | 29922 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2018 | 10383 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2012 | 5881 | 0.010 |
Why?
|
Chromosome Deletion | 1 | 2006 | 1385 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2010 | 3404 | 0.010 |
Why?
|
Cell Division | 1 | 2008 | 4475 | 0.010 |
Why?
|
Gene Deletion | 1 | 2008 | 2666 | 0.010 |
Why?
|
Translocation, Genetic | 1 | 2006 | 1394 | 0.010 |
Why?
|
Models, Genetic | 1 | 2010 | 3449 | 0.010 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2010 | 2942 | 0.010 |
Why?
|
Antigens, CD | 1 | 2010 | 4025 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2013 | 12976 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2010 | 17594 | 0.010 |
Why?
|
Survival Rate | 1 | 2011 | 12795 | 0.010 |
Why?
|
Child, Preschool | 2 | 2013 | 42500 | 0.010 |
Why?
|
Adult | 4 | 2013 | 223044 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2009 | 10729 | 0.010 |
Why?
|
Cell Line | 1 | 2010 | 15543 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2014 | 22223 | 0.010 |
Why?
|
Young Adult | 2 | 2013 | 59889 | 0.010 |
Why?
|
Risk Factors | 2 | 2014 | 74840 | 0.010 |
Why?
|
Neutrophils | 1 | 2008 | 3776 | 0.010 |
Why?
|
Aged | 3 | 2013 | 171117 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2013 | 81514 | 0.010 |
Why?
|
Brain | 1 | 2020 | 27171 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2008 | 14448 | 0.010 |
Why?
|
Middle Aged | 3 | 2013 | 223009 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2008 | 9525 | 0.010 |
Why?
|
Adolescent | 2 | 2013 | 88835 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2013 | 59489 | 0.000 |
Why?
|
Child | 1 | 2013 | 80564 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2011 | 65188 | 0.000 |
Why?
|